arrow
B

Benedikt Ley

Menzies School of Health Research and Charles Darwin University
H指数:39
被引数:4,142

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia

南亚疟疾前消除区跨边境间日疟原虫传播的遗传证据

2026-05-150
OA
Short-Course Low-Dose Primaquine for Radical Cure in G6PD-Normal Patients in the Pre-Elimination Context of Nepal

短疗程低剂量伯氨喹用于Nepal消除前背景中G6PD正常患者的彻底根治

2026-04-250
OAAI
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial

7天高剂量伯氨喹与单剂量阿托喹酮相对于14天低剂量伯氨喹在间日疟患者中的有效性与安全性(EFFORT):一项多中心、开放标签、随机对照、优效性试验

2026-02-110
OAAI
Systematic review and individual patient data meta-analysis on glucose-6-phosphate dehydrogenase activities measured by a semi-quantitative handheld biosensor

系统评价和基于半定量手持生物传感器测量的葡萄糖-6-磷酸脱氢酶活性的个体患者数据Meta分析

2025-11-200
OAAI
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis

使用系统综述和个体患者数据Meta分析,对伯氨喹剂量在间日疟中的疗效、耐受性和安全性进行自动化报告

2025-11-140
OAAI
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia

间日疟原虫短疗程根治方案的认知及其实施:柬埔寨利益相关者定性研究

2025-09-300
OAAI
Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis
2025-03-010
OAAI
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

Primaquine剂量和无并发症的间日疟患者的溶血风险: 系统评价和个体患者数据荟萃分析

2024-02-0112
OAAI
Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis

伯喹治疗南亚间日疟患者的安全性和有效性: 系统评价和个体患者数据荟萃分析

2023-12-203
OAAI
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
LANCET
IF88.5
2023-12-019
OAAI
Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysis
2023-10-128
OAAI
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
2023-09-066
OAAI
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
2023-09-041
OAAI
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
2022-12-2310
OAAI
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
2022-09-169
OAAI
Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis
2022-09-1417
OAAI